Works matching AU Garon, Edward B.

Results: 40

In vitro and in vivo evaluation and a case report of intense nanosecond pulsed electric field as a local therapy for human malignancies.
Published in:
International Journal of Cancer, 2007, v. 121, n. 3, p. 675, doi. 10.1002/ijc.22723
By:
- Garon, Edward B.;
- Sawcer, David;
- Vernier, P. Thomas;
- Tang, Tao;
- Sun, Yinghua;
- Marcu, Laura;
- Gundersen, Martin A.;
- Koeffler, H. Phillip
Publication type:
Article
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs.
Published in:
JAMA: Journal of the American Medical Association, 2014, v. 311, n. 19, p. 1998, doi. 10.1001/jama.2014.3741
By:
- Kris, Mark G.;
- Johnson, Bruce E.;
- Berry, Lynne D.;
- Kwiatkowski, David J.;
- Iafrate, A. John;
- Wistuba, Ignacio I.;
- Varella-Garcia, Marileila;
- Franklin, Wilbur A.;
- Aronson, Samuel L.;
- Pei-Fang Su;
- Yu Shyr;
- Camidge, D. Ross;
- Sequist, Lecia V.;
- Glisson, Bonnie S.;
- Khuri, Fadlo R.;
- Garon, Edward B.;
- Pao, William;
- Rudin, Charles;
- Schiller, Joan;
- Haura, Eric B.
Publication type:
Article
RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability.
Published in:
Drug Safety, 2022, v. 45, n. 1, p. 45, doi. 10.1007/s40264-021-01127-2
By:
- Nadal, Ernest;
- Horinouchi, Hidehito;
- Shih, Jin-Yuan;
- Nakagawa, Kazuhiko;
- Reck, Martin;
- Garon, Edward B.;
- Wei, Yu-Feng;
- Kollmeier, Jens;
- Frimodt-Moller, Bente;
- Barrett, Emily;
- Lipkovich, Olga;
- Visseren-Grul, Carla;
- Novello, Silvia
Publication type:
Article
Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities.
Published in:
NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00665-z
By:
- Lozac'hmeur, Ariane;
- Danek, Tyler;
- Yang, Qidi;
- Rosasco, Mario G.;
- Welch, John S.;
- Go, William Y.;
- Ng, Eric W.;
- Mardiros, Armen;
- Maloney, David G.;
- Garon, Edward B.;
- Kirtane, Kedar;
- Simeone, Diane M.;
- Molina, Julian R.;
- Salahudeen, Ameen A.;
- Stein, Michelle M.;
- Hecht, J. Randolph
Publication type:
Article
The Patient Journey in Non-Small-Cell Lung Cancer: An Overview.
Published in:
Conquer, 2020, v. 6, n. 4, p. 19
By:
- LEDEZMA, BLANCA A.;
- GARON, EDWARD B.
Publication type:
Article
Biomarker Testing in Non-Small-Cell Lung Cancer: A Guide for Patients.
Published in:
Conquer, 2020, v. 6, n. 3, p. 52
By:
- LEDEZMA, BLANCA A.;
- GARON, EDWARD B.
Publication type:
Article
Treatment of Non-Small-Cell Lung Cancer: A Guide for Patients.
Published in:
Conquer, 2020, v. 6, n. 2, p. 48
By:
- LEDZMA, BLANCA A.;
- GARON, EDWARD B.
Publication type:
Article
Staging of Non-Small-Cell Lung Cancer: A Guide for Patients.
Published in:
Conquer, 2020, v. 6, n. 1, p. 48
By:
- LEDZMA, BLANCA A.;
- GARON, EDWARD B.
Publication type:
Article
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC).
Published in:
Clinical Lung Cancer, 2021, v. 22, n. 4, p. 301, doi. 10.1016/j.cllc.2021.02.010
By:
- Garon, Edward B.;
- Cho, Byoung Chul;
- Reinmuth, Niels;
- Lee, Ki Hyeong;
- Luft, Alexander;
- Ahn, Myung-Ju;
- Robinet, Gilles;
- Le Moulec, Sylvestre;
- Natale, Ronald;
- Schneider, Jeffrey;
- Shepherd, Frances A.;
- Garassino, Marina Chiara;
- Geater, Sarayut Lucien;
- Szekely, Zsolt Papai;
- Van Ngoc, Tran;
- Liu, Feng;
- Scheuring, Urban;
- Patel, Nikunj;
- Peters, Solange;
- Rizvi, Naiyer A.
Publication type:
Article
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.
Published in:
2018
By:
- Ramalingam, Suresh S.;
- Pérol, Maurice;
- Reck, Martin;
- Kowalyszyn, Ruben Dario;
- Gautschi, Oliver;
- Kimmich, Martin;
- Eun Kyung Cho;
- Czyzewicz, Grzegorz;
- Grigorescu, Alexandru;
- Karaseva, Nina;
- Dakhil, Shaker;
- Pablo Lee;
- Zimmerman, Annamaria;
- Sashegyi, Andreas;
- Alexandris, Ekaterine;
- Carter, Gebra Cuyun;
- Winfree, Katherine B.;
- Garon, Edward B.;
- Cho, Eun Kyung;
- Lee, Pablo
Publication type:
journal article
Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results.
Published in:
2018
By:
- Reck, Martin;
- Garon, Edward B.;
- Paz-Ares, Luis;
- Ponce, Santiago;
- Jaime, Jesus Corral;
- Juan, Oscar;
- Nadal, Ernest;
- Katsuyuki Kiura;
- Widau, Ryan C.;
- He, Shuang;
- Dalal, Rita;
- Pablo Lee;
- Kazuhiko Nakagawa;
- Kiura, Katsuyuki;
- Lee, Pablo;
- Nakagawa, Kazuhiko
Publication type:
journal article
Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC).
Published in:
2018
By:
- Gaut, Daria;
- Myung Shin Sim;
- Yuguang Yue;
- Wolf, Brian R.;
- Abarca, Phillip A.;
- Carroll, James M.;
- Goldman, Jonathan W.;
- Garon, Edward B.;
- Sim, Myung Shin;
- Yue, Yuguang
Publication type:
journal article
Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation- Positive Metastatic Non—Small-Cell Lung Cancer.
Published in:
2017
By:
- Garon, Edward B.;
- Reck, Martin;
- Paz-Ares, Luis;
- Ponce, Santiago;
- Jaime, Jesus Corral;
- Juan, Oscar;
- Nadal, Ernest;
- Lee, Pablo;
- Dalai, Rita;
- Jingyi Liu;
- Shuang He;
- Treat, Joseph;
- Kazuhiko Nakagawa;
- Dalal, Rita;
- Liu, Jingyi;
- He, Shuang;
- Nakagawa, Kazuhiko
Publication type:
journal article
Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer.
Published in:
2015
By:
- Reynolds, Craig H;
- Patel, Jyoti D;
- Garon, Edward B;
- Olsen, Mark R;
- Bonomi, Philip;
- Govindan, Ramaswamy;
- Pennella, Eduardo J;
- Liu, Jingyi;
- Guba, Susan C;
- Li, Shi;
- Spigel, David R;
- Hermann, Robert C;
- Socinski, Mark A;
- Obasaju, Coleman K
Publication type:
journal article
Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed- Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer.
Published in:
Clinical Lung Cancer, 2015, v. 16, n. 3, p. 200, doi. 10.1016/j.cllc.2014.11.004
By:
- Reynolds, Craig H.;
- Patel, Jyoti D.;
- Garon, Edward B.;
- Olsen, Mark R.;
- Bonomi, Philip;
- Govindan, Ramaswamy;
- Pennella, Eduardo J.;
- Jingyi Liu;
- Guba, Susan C.;
- Shi Li;
- Spigel, David R.;
- Hermann, Robert C.;
- Socinski, Mark A.;
- Obasaju, Coleman K.
Publication type:
Article
A Randomized, Double-Blind, Phase III Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non– Small-Cell Lung Cancer After Disease Progression After 1 Previous Platinum-Based Therapy (REVEL): Treatment...
Published in:
Clinical Lung Cancer, 2012, v. 13, n. 6, p. 505, doi. 10.1016/j.cllc.2012.06.007
By:
- Garon, Edward B.;
- Dachuang Cao;
- Alexandris, Ekaterine;
- John, William J.;
- Yurasov, Sergey;
- Perol, Maurice
Publication type:
Article
Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists.
Published in:
Cancer Medicine, 2022, v. 11, n. 2, p. 530, doi. 10.1002/cam4.4459
By:
- Mileham, Kathryn F.;
- Schenkel, Caroline;
- Bruinooge, Suanna S.;
- Freeman‐Daily, Janet;
- Basu Roy, Upal;
- Moore, Amy;
- Smith, Robert A.;
- Garrett‐Mayer, Elizabeth;
- Rosenthal, Lauren;
- Garon, Edward B.;
- Johnson, Bruce E.;
- Osarogiagbon, Raymond U.;
- Jalal, Shadia;
- Virani, Shamsuddin;
- Weber Redman, Mary;
- Silvestri, Gerard A.
Publication type:
Article
The ascent of immune checkpoint inhibitors: is the understudy ready for a leading role?
Published in:
2017
By:
- Cummings, Amy L.;
- Garon, Edward B.
Publication type:
Editorial
Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small-cell lung cancer.
Published in:
Current Medical Research & Opinion, 2020, v. 36, n. 10, p. 1667, doi. 10.1080/03007995.2020.1808781
By:
- Yoh, Kiyotaka;
- Atagi, Shinji;
- Reck, Martin;
- Garon, Edward B.;
- Ponce Aix, Santiago;
- Moro-Sibilot, Denis;
- Winfree, Katherine B.;
- Frimodt-Moller, Bente;
- Zimmermann, Annamaria;
- Visseren-Grul, Carla;
- Nakagawa, Kazuhiko
Publication type:
Article
A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer.
Published in:
OncoTargets & Therapy, 2016, v. 9, p. 7275, doi. 10.2147/OTT.S109186
By:
- Garon, Edward B.;
- Neidhart, Jeffrey D.;
- Gabrail, Nashat Y.;
- de Oliveira, Moacyr R.;
- Balkissoon, Jai;
- Kabbinavar, Fairooz
Publication type:
Article
Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review.
Published in:
Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1247879
By:
- Garon, Edward B.;
- Visseren-Grul, Carla;
- Rizzo, Maria Teresa;
- Puri, Tarun;
- Chenji, Suresh;
- Reck, Martin
Publication type:
Article
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
Published in:
2016
By:
- Steuer, Conor E.;
- Behera, Madhusmita;
- Berry, Lynne;
- Kim, Sungjin;
- Rossi, Michael;
- Sica, Gabriel;
- Owonikoko, Taofeek K.;
- Johnson, Bruce E.;
- Kris, Mark G.;
- Bunn, Paul A.;
- Khuri, Fadlo R.;
- Garon, Edward B.;
- Ramalingam, Suresh S.
Publication type:
journal article
Uncertainty and psychological adjustment in patients with lung cancer.
Published in:
Psycho-Oncology, 2013, v. 22, n. 6, p. 1396, doi. 10.1002/pon.3155
By:
- Kurita, Keiko;
- Garon, Edward B.;
- Stanton, Annette L.;
- Meyerowitz, Beth E.
Publication type:
Article
Label-free enumeration, collection and downstream cytological and cytogenetic analysis of circulating tumor cells.
Published in:
Scientific Reports, 2016, p. 35474, doi. 10.1038/srep35474
By:
- Dhar, Manjima;
- Pao, Edward;
- Renier, Corinne;
- Go, Derek E.;
- Che, James;
- Montoya, Rosita;
- Conrad, Rachel;
- Matsumoto, Melissa;
- Heirich, Kyra;
- Triboulet, Melanie;
- Rao, Jianyu;
- Jeffrey, Stefanie S.;
- Garon, Edward B.;
- Goldman, Jonathan;
- Rao, Nagesh P.;
- Kulkarni, Rajan;
- Sollier-Christen, Elodie;
- Di Carlo, Dino
Publication type:
Article
Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review.
Published in:
Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01036
By:
- Rochigneux, Philippe;
- Garcia, Alejandro J.;
- Chanez, Brice;
- Madroszyk, Anne;
- Olive, Daniel;
- Garon, Edward B.
Publication type:
Article
Using Immune Checkpoint Inhibitors in Lung Cancer... includes discussion.
Published in:
Oncology (08909091), 2016, v. 30, n. 8, p. 713
By:
- Marrone, Kristen A.;
- Brahmer, Julie R.;
- Garon, Edward B.
Publication type:
Article
Management of Small-Cell Lung Cancer: Time to Move Forward.
Published in:
Oncology (08909091), 2010, v. 24, n. 11, p. 1043
By:
- Pollock, Juliet;
- Garon, Edward B.
Publication type:
Article
Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study.
Published in:
Supportive Care in Cancer, 2021, v. 29, n. 1, p. 117, doi. 10.1007/s00520-020-05459-0
By:
- Garon, Edward B.;
- Winfree, Katherine B.;
- Molife, Cliff;
- Cui, Zhanglin Lin;
- Arriola, Edurne;
- Levy, Benjamin;
- Mekhail, Tarek;
- Pérol, Maurice
Publication type:
Article
Highlights In Non-Small Cell Lung Cancer From the IASLC 2023 World Conference on Lung Cancer: Commentary.
Published in:
Clinical Advances in Hematology & Oncology, 2023, v. 21, p. 13
By:
- Garon, Edward B.
Publication type:
Article
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small cell lung cancer: exposure-response relationship.
Published in:
2022
By:
- Nakagawa, Kazuhiko;
- Garon, Edward B.;
- Gao, Ling;
- Callies, Sophie;
- Zimmermann, Annamaria;
- Walgren, Richard;
- Visseren-Grul, Carla;
- Reck, Martin
Publication type:
journal article
Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer.
Published in:
2018
By:
- Smit, Egbert F.;
- Garon, Edward B.;
- Reck, Martin;
- Cappuzzo, Federico;
- Bidoli, Paolo;
- Cohen, Roger B.;
- Gao, Ling;
- O’Brien, Lisa M.;
- Lee, Pablo;
- Zimmermann, Annamaria;
- Ferry, David R.;
- Melemed, Allen S.;
- Pérol, Maurice;
- O'Brien, Lisa M
Publication type:
journal article
Alectinib Induces a Durable (>15 Months) Complete Response in an ALK-Positive Non-Small Cell Lung Cancer Patient Who Progressed on Crizotinib With Diffuse Leptomeningeal Carcinomatosis.
Published in:
2015
By:
- Ou, Sai‐Hong Ignatius;
- Sommers, Karen R.;
- Azada, Michele C.;
- Garon, Edward B.
Publication type:
Case Study
Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients.
Published in:
Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.572895
By:
- Liu, Haiyan E.;
- Vuppalapaty, Meghah;
- Wilkerson, Charles;
- Renier, Corinne;
- Chiu, Michael;
- Lemaire, Clementine;
- Che, James;
- Matsumoto, Melissa;
- Carroll, James;
- Crouse, Steve;
- Hanft, Violet R.;
- Jeffrey, Stefanie S.;
- Di Carlo, Dino;
- Garon, Edward B.;
- Goldman, Jonathan;
- Sollier, Elodie
Publication type:
Article
Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY.
Published in:
Cancer Science, 2020, v. 111, n. 12, p. 4510, doi. 10.1111/cas.14655
By:
- Nishio, Makoto;
- Seto, Takashi;
- Reck, Martin;
- Garon, Edward B.;
- Chiu, Chao‐Hua;
- Yoh, Kiyotaka;
- Imamura, Fumio;
- Park, Keunchil;
- Shih, Jin‐Yuan;
- Visseren‐Grul, Carla;
- Frimodt‐Moller, Bente;
- Zimmermann, Annamaria;
- Homma, Gosuke;
- Enatsu, Sotaro;
- Nakagawa, Kazuhiko
Publication type:
Article
Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 339, doi. 10.1007/s00262-022-03252-y
By:
- Gao, Yinjie;
- Stein, Michelle M.;
- Kase, Matthew;
- Cummings, Amy L.;
- Bharanikumar, Ramit;
- Lau, Denise;
- Garon, Edward B.;
- Patel, Sandip P.
Publication type:
Article
Targeted Therapy Approaches for MET Abnormalities in Non-Small Cell Lung Cancer.
Published in:
Drugs, 2021, v. 81, n. 5, p. 547, doi. 10.1007/s40265-021-01477-2
By:
- Garon, Edward B.;
- Brodrick, Paige
Publication type:
Article
Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis.
Published in:
Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24457-2
By:
- Li, Shuo;
- Noor, Zorawar S.;
- Zeng, Weihua;
- Stackpole, Mary L.;
- Ni, Xiaohui;
- Zhou, Yonggang;
- Yuan, Zuyang;
- Wong, Wing Hung;
- Agopian, Vatche G.;
- Dubinett, Steven M.;
- Alber, Frank;
- Li, Wenyuan;
- Garon, Edward B.;
- Zhou, Xianghong Jasmine
Publication type:
Article
High prevalence of lung cancer in a surgical cohort of lung cancer patients a decade after smoking cessation.
Published in:
Journal of Cardiothoracic Surgery, 2011, v. 6, n. 1, p. 19, doi. 10.1186/1749-8090-6-19
By:
- Mong, Cindy;
- Garon, Edward B.;
- Fuller, Clark;
- Mahtabifard, Ali;
- Mirocha, James;
- Mosenifar, Zab;
- McKenna, Robert
Publication type:
Article
<sup>18</sup>F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib.
Published in:
Journal of Nuclear Medicine, 2011, v. 52, n. 11, p. 1684, doi. 10.2967/jnumed.111.095257
By:
- Benz, Matthias R.;
- Herrmann, Ken;
- Walter, Franziska;
- Garon, Edward B.;
- Reckamp, Karen L.;
- Figlin, Robert;
- Phelps, Michael E.;
- Weber, Wolfgang A.;
- Czernin, Johannes;
- Allen-Auerbach, Martin S.
Publication type:
Article
Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor-related Pneumonitis. An Official American Thoracic Society Research Statement.
Published in:
2019
By:
- Sears, Catherine R.;
- Peikert, Tobias;
- Possick, Jennifer D.;
- Naidoo, Jarushka;
- Nishino, Mizuki;
- Patel, Sandip P.;
- Camus, Philippe;
- Gaga, Mina;
- Garon, Edward B.;
- Gould, Michael K.;
- Limper, Andrew H.;
- Montgrain, Philippe R.;
- Travis, William D.;
- Rivera, M. Patricia
Publication type:
journal article